This content is machine translated Multiple sclerosis Effective therapy management also protects brain volume Each year, a person loses about 0.2-0.4% of their brain volume. So far, so normal. In patients with multiple sclerosis, however, this value is about twice as high. This is due…
View Post 3 min This content is machine translated "Medication Overuse Headache" (MOH). What does the updated S1 guideline say? The 2022 updated guideline incorporates the latest recommendations of the International Headache Society as well as current study findings on drug interventions. Antibodies directed against CGRP or its receptor have…
View Post 4 min This content is machine translated Amendment of the Swiss Narcotics Law Cannabis medicines now usable without exceptional approval Interest in the medicinal use of cannabinoids has increased greatly in recent years due to their wide range of applications and numerous reports of successful treatments. As of August 1,…
View Post 9 min This content is machine translated Drug interactions Refresher – Do’s and dont’s at a glance Patients would make the title of this post more authoritative: Do my physicians safely protect me from avoidable risks due to inappropriate combination of drugs? This illustrates the standard to… CME-Test
View Post 3 min This content is machine translated Brain diseases Supply strategies discussed on an interdisciplinary basis Representatives from neurology, psychiatry and pharmacy met for the first time at the Berlin Brain Summit for an interdisciplinary summit on brain diseases. The aim of the inter-professional exchange was…
View Post 5 min This content is machine translated Pain therapy for rheumatic inflammatory diseases It doesn’t always have to be an opioid For patients with rheumatic diseases, pain is the central problem. However, recent studies show that influencing pain experience with biologics is possible and that JAK inhibitors can provide rapid, direct…
View Post 3 min This content is machine translated Vascular dementia Ginkgo biloba extract, cholinesterase inhibitor, or both? In a retrospective study, 12 months of treatment with a Ginkgo biloba special extract as monotherapy or in combination with cholinesterase inhibitors resulted in a reduction in cognitive and neuropsychiatric symptoms…
View Post 4 min This content is machine translated Neurointensive Care Focus on interprofessional delirium management Treating the critically ill demands the highest levels of concentration, up-to-date knowledge and rapid action from hospital staff. The Congress of Neurointensive Medicine therefore explicitly addressed scientific advances, collaboration between…
View Post 2 min This content is machine translated Cannabis Controlled release pilot launched for non-medical purposes As a joint project of the University of Basel, the University Psychiatric Clinics and the Basel-Stadt Health Department, the FOPH has now approved the first pilot trial for the controlled…
View Post 3 min This content is machine translated Study Report Ginkgo biloba and rivaroxaban: no indication of relevant interactions Ginkgo-containing preparations can alleviate neuropsychiatric complaints and are widely used, especially for the treatment of cognitive performance deficits. But what about the combinability with anticoagulant agents? In a recently published…
View Post 3 min This content is machine translated SARS-CoV-2 In vitro study of the effects of a bacterial lysate in human epithelial tissue. Study results from a research team at the Department of Biomedicine at University Hospital Basel support the hypothesis that the bacterial lysate OM-85 may have utility in preventing SARS-CoV-2 infection…
